Kimberly Nix in the hospital. Three years after being diagnosed with metastatic sarcoma, Dr. Kimberley Nix died on Wednesday, May 8. The 31-year-old from Calgary, Alberta, first gained attention in ...
Add Yahoo as a preferred source to see more of our stories on Google. Kimberley Nix was a 28-year-old medical resident when she was diagnosed with metastatic sarcoma. Today, she continues her studies ...
Please provide your email address to receive an email when new articles are posted on . Sandra D’Angelo, MD, talked about a study examining the role of tumor-infiltrating lymphocyte, or TIL, in ...
Ewing sarcoma is a malignant type of bone tumor, meaning it is a form of cancer that spreads. According to a 2024 review, Ewing sarcoma is the second most common primary cancerous bone tumor. It ...
A novel intratumoral treatment was administered to the first patient in a phase 3 trial for certain patients with metastatic soft tissue sarcoma. A phase 3 trial for patients with metastatic soft ...
Intensity Therapeutics’ stock has risen nearly 400% after its oncology candidate showed high overall survival (OS) and disease control. In the Phase I/II trial (NCT03058289), INT230-6 showed a disease ...
Here, we report the case of a patient with metastatic UPS of the chest wall successfully treated with an anti–PD-L1 ICI at the Clinical Trial Unit of the Hospital Clinic of Barcelona (HCB), who ...
Soft tissue sarcomas rarely metastasize to the heart, with cardiac involvement seen in less than 0.03% of cases. Metastatic heart disease presents diagnostic challenges due to nonspecific symptoms, ...
C-Further to advance its first two bespoke paediatric cancer therapeutics in collaboration with leading global academic and industry investigators Selected programmes to potentially address multiple ...
Kimberley Nix was a 28-year-old medical resident when she was diagnosed with metastatic sarcoma. Today, she continues her studies while sharing her journey on social media Stephanie Sengwe is a pop ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results